There is some evidence that
carvedilol can cause a small to moderate rise in
ciclosporin levels (requiring a gradual
ciclosporin dose reduction of 20%, over about 3 months, to maintain levels within the therapeutic range).
This interaction is unconfirmed and of uncertain
clinical significance. There is insufficient evidence to recommend increased monitoring, but be aware of the potential for an interaction in case of an unexpected response to treatment.